Short Interest in iSpecimen Inc. (NASDAQ:ISPC) Rises By 390.5%

iSpecimen Inc. (NASDAQ:ISPC) saw a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 41,200 shares, an increase of 390.5% from the October 15th total of 8,400 shares. Approximately 5.4% of the company’s shares are short sold. Based on an average trading volume of 395,600 shares, the days-to-cover ratio is currently 0.1 days.

iSpecimen Stock Performance

NASDAQ:ISPC traded up $0.05 on Thursday, hitting $4.35. 272,501 shares of the stock were exchanged, compared to its average volume of 195,162. The stock has a market capitalization of $4.18 million, a price-to-earnings ratio of -0.23 and a beta of 1.59. iSpecimen has a 52 week low of $3.41 and a 52 week high of $12.59. The company’s 50-day moving average price is $4.18 and its 200 day moving average price is $1.65.

iSpecimen Company Profile

iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.